Erin Beattie
Biography
Erin Beattie is the Network Manager for the Neuromuscular Disease Network for Canada (NMD4C), where she leads the coordination of all network activities, fostering collaboration across clinical, research, and advocacy communities. With a deep commitment to strengthening neuromuscular and rare disease capacity in Canada, Erin plays a pivotal role in connecting stakeholders, supporting strategic initiatives, and advancing national programming. She holds a PhD in Laboratory Medicine & Pathobiology from the University of Toronto and an MSc in Pharmacology from Dalhousie University, with research focused on cardiac remodeling in heart failure. Prior to joining NMD4C, she worked as a Research & Development Scientist and Medical Writer at a clinical research organization specializing in respiratory trials, served as a Clinical Science Consultant, and coordinated research at the IBD Centre at the Children’s Hospital of Eastern Ontario (CHEO). Erin is dedicated to building sustainable networks and strengthening Canada’s neuromuscular and rare disease research landscape.
Recent Publications
Balan, J, Larson, NB. Reproducibility of digital pathology features extracted from deep learning and foundational AI models on sequential tissue slides. Sci Rep. 2025. PMID:41353287
Zuo, Y, Yang, SY, Qian, XK, Liu, K. Analysis of hub genes temporal dynamics in cardiac ischemia/reperfusion injury: a bioinformatics and experimental study. Front Physiol. 2025.16 1668586 PMID:41347019
Feng, WT, Yao, R, Xu, LJ, Zhong, XM, Liu, H, Sun, Y et al.. Retraction Note: Effect of miR-363 on the proliferation, invasion and apoptosis of laryngeal cancer by targeting Mcl-1. Eur Rev Med Pharmacol Sci. 2025.29 (11)492 PMID:41342069
Lou, KX, Li, ZH, Wang, P, Liu, Z, Chen, Y, Wang, XL et al.. Retraction Note: Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion. Eur Rev Med Pharmacol Sci. 2025.29 (11)491 PMID:41342068
Xia, LH, Yan, QH, Sun, QD, Gao, YP. Retraction Note: MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1. Eur Rev Med Pharmacol Sci. 2025.29 (11)490 PMID:41342067
Nair K, Umapathy K, Farid T, Masse S, Mueller E, Sivanandan RV, Poku K, Rao V, Nair V, Butany J, Ideker RE, Nanthakumar K.Intramural activation during early human ventricular fibrillation. Circ Arrhythm Electrophysiol, 4(5): 692-703, 2011.
Mueller EE, Momen A, Massé S, Zhou YQ, Liu J, Backx PH, Henkelman RM, Nanthakumar K, Stewart DJ, Husain M.Electrical remodelling precedes heart failure in an endothelin-1 induced model of cardiomyopathy. Cardiovasc Res, 89(3): 623-33, 2011.
Mueller EE, Grandy SA, Ferrier GR, Howlett SE.PKA-mediated phosphorylation contributes to enhanced contraction observed in mice that over-express β-adrenergic receptor kinase--1. J Pharmacol Exp Ther, Dec; 319(3): 1307-16, 2006.
Grandy SA, Mueller EE, Ferrier GR, Howlett SE.The role of β-adrenergic receptor signaling in regulation of cardiac contraction. Recent Res Dev Physiol, 2: 1-19, 2004.
See more on PubMed